Top
image credit: Freepik

Two new cancer pills show ‘unprecedented’ results in boosting survival rates and preventing recurrence

June 7, 2023

Via: Fox News
Category:

Potentially “practice-changing” results from two new cancer drug studies were introduced at the American Society of Clinical Oncology (ASCO)’s annual meeting this week in Chicago.

For lung cancer patients, a drug called osimertinib — taken by pill once daily — was shown to reduce the risk of deaths by more than 50% in a long-running international study.

For breast cancer patients, a new drug called ribociclib significantly increased survival rates and prevented recurring disease in a separate study.

Read More on Fox News